AUTHOR=Xu Hui , Guo Chenguang , Luo Feifei , Sotoodeh Romina , Zhang Ming , Wang Yuan TITLE=Subcortical Brain Abnormalities and Clinical Relevance in Patients With Hemifacial Spasm JOURNAL=Frontiers in Neurology VOLUME=10 YEAR=2020 URL=https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2019.01383 DOI=10.3389/fneur.2019.01383 ISSN=1664-2295 ABSTRACT=

Purpose: Hemifacial spasm (HFS), a rare neuromuscular movement disorder, is characterized by unilateral, irregular, and paroxysmal facial muscle contractions. To explore the central neural mechanisms of HFS, we conducted vertex-wise shape analyses to investigate volume and shape alterations of subcortical structures, which could help to better understand the abnormality in distinct subcortical regions and determine alternative biomarkers of HFS.

Methods: Thirty patients with HFS and 30 age- and sex-matched healthy controls provided written informed consent. T1-weighted structural magnetic resonance imaging (MRI) data were collected from all participants. Vertex-wise shape analyses were performed to assess the volume and shape alterations of subcortical structures following HFS. Post hoc correlations with spasm severity and measures of mood dysfunction were applied to characterize subcortical brain alterations.

Results: Compared with healthy controls, patients with HFS showed increased volume in the right caudate specifically. Furthermore, patients exhibited significant shape atrophy in the anterior medial aspect of left pallidum, together with shape expansion in the anterior ventrolateral aspect of right caudate head. In addition, shape alteration in right caudate was positively correlated with both anxiety and depression severity in patients with HFS.

Conclusions: This is the first study to employ vertex-wise shape analysis to investigate subcortical brain abnormalities in patients with HFS. Our findings provide compelling evidence for subcortical brain alterations specific to HFS, and further may shed light on the pathophysiology of HFS and apply to the translational medicine.